DK623186A - Polypeptid med vaevsplasminogen-aktivator-virkning - Google Patents
Polypeptid med vaevsplasminogen-aktivator-virkningInfo
- Publication number
- DK623186A DK623186A DK623186A DK623186A DK623186A DK 623186 A DK623186 A DK 623186A DK 623186 A DK623186 A DK 623186A DK 623186 A DK623186 A DK 623186A DK 623186 A DK623186 A DK 623186A
- Authority
- DK
- Denmark
- Prior art keywords
- plasminogen activator
- tissue plasminogen
- polypeptide
- activator effect
- fibrin
- Prior art date
Links
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title abstract 4
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title abstract 4
- 229960000187 tissue plasminogen activator Drugs 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000009123 Fibrin Human genes 0.000 abstract 2
- 108010073385 Fibrin Proteins 0.000 abstract 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 2
- 229950003499 fibrin Drugs 0.000 abstract 2
- 102000010752 Plasminogen Inactivators Human genes 0.000 abstract 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 abstract 1
- 230000001342 plasminogenolytic effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81287985A | 1985-12-23 | 1985-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK623186D0 DK623186D0 (da) | 1986-12-22 |
DK623186A true DK623186A (da) | 1987-08-26 |
Family
ID=25210860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK623186A DK623186A (da) | 1985-12-23 | 1986-12-22 | Polypeptid med vaevsplasminogen-aktivator-virkning |
Country Status (10)
Country | Link |
---|---|
US (4) | US5501853A (fr) |
EP (1) | EP0227462B1 (fr) |
JP (4) | JP2575369B2 (fr) |
AT (1) | ATE74379T1 (fr) |
AU (1) | AU605124B2 (fr) |
DE (1) | DE3684680D1 (fr) |
DK (1) | DK623186A (fr) |
ES (1) | ES2031826T3 (fr) |
GR (1) | GR3004568T3 (fr) |
ZA (1) | ZA869626B (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI89723C (fi) * | 1984-10-01 | 1993-11-10 | Genzyme Corp | Foerfarande foer framstaellning av vaevnadsplasminogenaktivator, kodande rekombinant-dna daerav och en transformanscell |
EP0227462B1 (fr) * | 1985-12-23 | 1992-04-01 | Chiron Corporation | Activateurs peptidiques de plasminogène |
US5258298A (en) * | 1986-01-31 | 1993-11-02 | Genetics Institute, Inc. | Deletion and glycosylation mutant of human tissue plasminogen activator |
US5837518A (en) * | 1986-01-31 | 1998-11-17 | Genetics Institute, Inc. | Thrombolytic proteins |
US5002887A (en) * | 1986-01-31 | 1991-03-26 | Genetics Institute, Inc. | Truncated thrombolytic proteins |
DE3789664T3 (de) * | 1986-01-31 | 2004-09-16 | Genetics Institute, LLC, Cambridge | Neue thrombolytische proteine. |
EP0234051B1 (fr) * | 1986-02-17 | 1991-12-11 | Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis | Mutants de l'activateur de plasminogène tissulaire; information recombinante génétique codant pour celui-ci et procédéde préparation de ces mutants, leur application et compositions pharmaceutiques |
IE81073B1 (en) * | 1986-03-18 | 2000-01-12 | Genentech Inc | Modified human tissue-type plasminogen activator and its preparation |
US5047241A (en) * | 1986-07-11 | 1991-09-10 | American Home Products Corporation | Tris-Kringle plasminogen activator with novel K2 insert |
US5580559A (en) * | 1986-12-05 | 1996-12-03 | Ciba-Geigy Corporation | Hybrid plasminogen activator |
US5242819A (en) * | 1986-12-05 | 1993-09-07 | Ciba-Geigy Corporation | DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase |
NO882226L (no) * | 1987-05-22 | 1988-11-23 | Zymogenetics Inc | Fibrinolytiske proteiner. |
US5149533A (en) * | 1987-06-04 | 1992-09-22 | Zymogenetics, Inc. | Modified t-PA with kringle-/replaced by another kringle |
SE8702562L (sv) * | 1987-06-18 | 1988-12-19 | Kabigen Ab | Nya fibrinolytiska enzymer |
US5302390A (en) * | 1987-07-01 | 1994-04-12 | Beecham Group Plc | Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment |
JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
US4963357A (en) * | 1987-10-09 | 1990-10-16 | Monsanto Company | Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor |
US5244676A (en) * | 1987-10-09 | 1993-09-14 | Monsanto Company | Modified tissue plasminogen activator with modified glycosylation site |
US5037752A (en) * | 1987-10-09 | 1991-08-06 | Monsanto Company | Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277 |
ZA887556B (en) * | 1987-10-09 | 1989-07-26 | Monsanto Co | Modified tissue plasminogen activator |
AU618039B2 (en) * | 1987-10-29 | 1991-12-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel polypeptide compounds |
US5094953A (en) * | 1988-03-21 | 1992-03-10 | Genentech, Inc. | Human tissue plasminogen activator variants |
US5270198A (en) * | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
US5346824A (en) * | 1988-05-20 | 1994-09-13 | Genentech, Inc. | DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof |
IL90146A (en) * | 1988-05-20 | 1994-10-07 | Genentech Inc | Glycosylation derivatives of tissue plasminogen activator |
DE3823805A1 (de) * | 1988-07-14 | 1990-01-18 | Basf Ag | Neue polypeptide, ihre herstellung und verwendung |
US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
US5258180A (en) * | 1988-09-02 | 1993-11-02 | Genetech, Inc. | Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment |
US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
US5070021A (en) * | 1989-01-10 | 1991-12-03 | Monsanto Company | Method of modifying oligosaccharide structure of tissue plasminogen activator |
CA2007364A1 (fr) * | 1989-01-17 | 1990-07-17 | David J. Livingston | Sequences de genes encodant des residus modifies situes dans le domaine protease du tpa |
IT1243774B (it) * | 1990-08-02 | 1994-06-28 | Erba Carlo Spa | Derivati della prourochinasi |
US5223408A (en) * | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
AU664469B2 (en) * | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
EP1171615B1 (fr) | 1999-04-26 | 2006-12-13 | Genentech, Inc. | Procede de culture cellulaire pour glycoproteines |
US6649597B1 (en) * | 2000-06-22 | 2003-11-18 | The University Of Iowa Research Foundation | Targeting vector to the urokinase plasminogen activator receptor |
AU2000268170A1 (en) * | 2000-09-04 | 2002-03-22 | Hunan Royal Biotech | A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation |
IL145209A0 (en) * | 2000-09-06 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
KR100701265B1 (ko) * | 2006-01-16 | 2007-04-02 | 대한민국 | 재조합 사람 조직형 플라스미노겐 활성인자 발현벡터 및 플라스미노겐 활성인자를 소변으로 분비하는 형질전환돼지 생산방법 |
KR100834561B1 (ko) * | 2006-12-08 | 2008-06-02 | 가톨릭대학교 산학협력단 | 크링글 도메인 1 및 2로 이루어진 비-글리코실화 재조합단백질, 그 제조 방법 및 이를 포함하는 조성물 |
WO2009099631A1 (fr) * | 2008-02-08 | 2009-08-13 | Miles Lindsey A | Nouveau récepteur du plasminogène, polypeptides et anticorps associés |
KR100855024B1 (ko) | 2008-04-30 | 2008-08-28 | 가톨릭대학교 산학협력단 | 크링글 도메인 1 및 2 로 이루어진 비-글리코실화 재조합단백질 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79202B (fr) * | 1982-05-05 | 1984-10-22 | Genentech Inc | |
ZA833174B (en) * | 1982-05-05 | 1984-08-29 | Genentech Inc | Human tissue plasminogen activator |
WO1984001786A1 (fr) * | 1982-10-28 | 1984-05-10 | Beecham Group Plc | Derives d'enzymes et leur utilisation dans le traitement de la thrombose |
GB8401786D0 (en) | 1984-01-24 | 1984-02-29 | Ray M S | Design and operation of adsorbent container |
US4753879A (en) * | 1984-08-27 | 1988-06-28 | Biogen N.V. | Modified tissue plasminogen activators |
FI89723C (fi) * | 1984-10-01 | 1993-11-10 | Genzyme Corp | Foerfarande foer framstaellning av vaevnadsplasminogenaktivator, kodande rekombinant-dna daerav och en transformanscell |
DE3537176C2 (de) * | 1984-10-18 | 1994-06-09 | Zymogenetics Inc | Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung |
JPS61247384A (ja) * | 1984-10-18 | 1986-11-04 | チモ−ジエネテイツクス インコ−ポレ−テツド | 酵母中でプラスミノ−ゲン活性化因子を発現する方法 |
GB8503358D0 (en) * | 1985-02-09 | 1985-03-13 | Beecham Group Plc | Compounds |
EP0201153A3 (fr) * | 1985-02-09 | 1987-10-07 | Beecham Group Plc | Enzyme modifié et son procédé de préparation |
US5073494A (en) * | 1985-04-22 | 1991-12-17 | Genentech, Inc. | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 |
DE3682104D1 (de) * | 1985-04-22 | 1991-11-28 | Genentech Inc | Plasminogenaktivator-mutante des menschlichen gewebes, verfahren und zwischenprodukte dafuer und diese mutante verwendende zusammensetzungen. |
JPH0811066B2 (ja) * | 1985-09-30 | 1996-02-07 | インテグレーテッド・ジエネティックス・インコーポレーテッド | 組換えdnaが生産するヒト子宮プラスミノ−ゲンアクチベ−タ− |
GB8528321D0 (en) * | 1985-11-18 | 1985-12-24 | Ciba Geigy Ag | Modified fibrinolytic agents |
WO1987003906A1 (fr) * | 1985-12-20 | 1987-07-02 | The Upjohn Company | Analogues d'un activateur de plasminogene tissulaire (tpa) |
US5106741A (en) * | 1985-12-20 | 1992-04-21 | The Upjohn Company | Tissue plasminogen activator (TPA) analogs |
EP0227462B1 (fr) * | 1985-12-23 | 1992-04-01 | Chiron Corporation | Activateurs peptidiques de plasminogène |
EP0234051B1 (fr) * | 1986-02-17 | 1991-12-11 | Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis | Mutants de l'activateur de plasminogène tissulaire; information recombinante génétique codant pour celui-ci et procédéde préparation de ces mutants, leur application et compositions pharmaceutiques |
US4751084A (en) * | 1986-02-26 | 1988-06-14 | Monsanto Company | Tissue plasminogen activator from normal human colon cells |
IE81073B1 (en) * | 1986-03-18 | 2000-01-12 | Genentech Inc | Modified human tissue-type plasminogen activator and its preparation |
ATE90967T1 (de) * | 1986-03-28 | 1993-07-15 | Creative Biomolecules Inc | Proteinanaloge des gewebs-plasminogenaktivators. |
JPH0761266B2 (ja) * | 1986-07-03 | 1995-07-05 | 株式会社ミドリ十字 | 変異ヒトプロウロキナ−ゼ |
DK345087A (da) * | 1986-07-11 | 1988-01-12 | Novo Industri As | Modificeret vaevsplasminogenaktivator |
EP0266032A1 (fr) * | 1986-08-29 | 1988-05-04 | Beecham Group Plc | Enzyme fibrinolytique modifiée |
PT86162B (pt) * | 1986-11-21 | 1990-11-20 | Smithkline Beecham Corp | Expressao de proteina recombinante |
NL8700013A (nl) * | 1987-01-06 | 1988-08-01 | Leuven Res & Dev Vzw | Hybride plasminogeenactivatoren met verbeterde trombolytische eigenschappen en geneesmiddelen die deze plasminogeenactivatoren bevatten. |
GB8705377D0 (en) * | 1987-03-07 | 1987-04-08 | Beecham Group Plc | Compounds |
US5009888A (en) * | 1987-04-13 | 1991-04-23 | Genzyme Corporation | Therapeutic enzyme-antibody complexes |
US5258180A (en) * | 1988-09-02 | 1993-11-02 | Genetech, Inc. | Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment |
-
1986
- 1986-12-22 EP EP86310009A patent/EP0227462B1/fr not_active Expired - Lifetime
- 1986-12-22 DE DE8686310009T patent/DE3684680D1/de not_active Expired - Fee Related
- 1986-12-22 AT AT86310009T patent/ATE74379T1/de not_active IP Right Cessation
- 1986-12-22 DK DK623186A patent/DK623186A/da not_active Application Discontinuation
- 1986-12-22 ZA ZA869626A patent/ZA869626B/xx unknown
- 1986-12-22 US US06/944,117 patent/US5501853A/en not_active Expired - Lifetime
- 1986-12-22 AU AU66830/86A patent/AU605124B2/en not_active Ceased
- 1986-12-22 ES ES198686310009T patent/ES2031826T3/es not_active Expired - Lifetime
- 1986-12-23 JP JP61316095A patent/JP2575369B2/ja not_active Expired - Lifetime
-
1992
- 1992-05-12 GR GR920400916T patent/GR3004568T3/el unknown
-
1994
- 1994-03-10 US US08/208,202 patent/US5439679A/en not_active Expired - Lifetime
- 1994-08-08 JP JP6186171A patent/JP2681000B2/ja not_active Expired - Lifetime
- 1994-08-08 JP JP6186170A patent/JP2680999B2/ja not_active Expired - Lifetime
-
1995
- 1995-01-31 US US08/381,308 patent/US5656269A/en not_active Expired - Fee Related
-
1996
- 1996-12-17 JP JP8337365A patent/JP2769314B2/ja not_active Expired - Lifetime
-
1997
- 1997-02-13 US US08/799,823 patent/US5976530A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5501853A (en) | 1996-03-26 |
JP2769314B2 (ja) | 1998-06-25 |
JPS62253380A (ja) | 1987-11-05 |
ES2031826T3 (es) | 1993-01-01 |
JP2575369B2 (ja) | 1997-01-22 |
GR3004568T3 (fr) | 1993-04-28 |
EP0227462A3 (en) | 1987-10-07 |
US5976530A (en) | 1999-11-02 |
JP2681000B2 (ja) | 1997-11-19 |
JPH0775583A (ja) | 1995-03-20 |
AU605124B2 (en) | 1991-01-10 |
US5439679A (en) | 1995-08-08 |
AU6683086A (en) | 1987-06-25 |
JPH0787973A (ja) | 1995-04-04 |
JPH09187287A (ja) | 1997-07-22 |
ZA869626B (en) | 1987-10-28 |
EP0227462A2 (fr) | 1987-07-01 |
JP2680999B2 (ja) | 1997-11-19 |
US5656269A (en) | 1997-08-12 |
DK623186D0 (da) | 1986-12-22 |
DE3684680D1 (de) | 1992-05-07 |
ATE74379T1 (de) | 1992-04-15 |
EP0227462B1 (fr) | 1992-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK623186A (da) | Polypeptid med vaevsplasminogen-aktivator-virkning | |
ATE63748T1 (de) | Enzymwiderstandsfaehige immunomodulatorische peptide. | |
IE860328L (en) | Expression of protein c | |
DE69231469D1 (de) | Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen | |
ATE224713T1 (de) | Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression | |
DK0601154T3 (da) | BPC-peptider, deres fremstilling og anvendelse | |
ATE118009T1 (de) | Substituierte alpha-aminosäuren mit pharmazeutischer aktivität. | |
LV10108A (lv) | Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni | |
DK50987A (da) | Polypeptid med plasminogenaktivatorvirkning | |
KR890004724A (ko) | 신규 프로테아제 제제(製劑) | |
DK270489D0 (da) | Protein med thrombininhiberende virkning, fremgangsmaade til dets isolering, samt dets anvendelse som laegemiddel | |
ATE78292T1 (de) | Plasminogen-aktivator und thrombolytische zusammensetzung. | |
DE3854195D1 (de) | Polypeptid-verbindungen. | |
DE69105213D1 (de) | Substitutionsvariante des gewebeplasminogenaktivators. | |
ATE28186T1 (de) | Alpha-allenyl-alpha-amino carbonsaeuren. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |